Aims/hypothesis-The purpose of this study was to investigate whether the association of glycaemic control with cognitive function is modulated by the haptoglobin 1-1 (Hp 1-1) genotype in cognitively normal elderly with type 2 diabetes.Methods-In this cross-sectional study, we examined 793 participants who were genotyped for Hp (80 Hp 1-1 carriers and 713 Hp 1-1 non-carriers) enrolled in the Israel Diabetes and Cognitive Decline (IDCD) study. Glycaemic control was operationally defined by HbA 1c level. The outcome measures were performance in four cognitive domains (episodic memory, attention/working memory, language/semantic categorisation, executive function) and overall cognition, a composite of the domains. Effect sizes were obtained from hierarchical linear regression analyses for each outcome measure, controlling for demographics, type 2 diabetes-related characteristics, cardiovascular risk factors, and their interactions with Hp genotype.Results-Interaction analyses showed significantly stronger associations of HbA 1c with poorer cognitive function among Hp 1-1 carriers than non-carriers; attention/working memory (p < 0.001)Corresponding author: Elizabeth Guerrero-Berroa, James J. Peters VA Medical Center, 130 West Kingsbridge Road, Room 1F-01, Bronx, NY 10468, USA elizabeth.guerrero-berroa@mssm.edu. Contribution statement MSB led the development of the study design. RRS and AH collaborated in planning the study design. MSB, RRS, AH and AL contributed to the data research. MSB, RRS and AH contributed to data collection. JS performed the statistical analysis. EGB conducted the literature search and wrote the manuscript. MSB and JS contributed to the writing of the manuscript. All coauthors contributed to the interpretation of results, critically revised the manuscript and gave final approval. EGB is the guarantor of this work.
Duality of interestThe authors declare that there is no duality of interest associated with this study. and overall cognition (p = 0.003). For these two cognitive domains, associations were significant for Hp 1-1 carriers despite the small sample size (p < 0.00001 and p = 0.001, respectively), but not for non-carriers.
HHS Public AccessConclusions/interpretation-Our findings suggest that patients with type 2 diabetes and poor glycaemic control carrying the Hp 1-1 genotype may be at increased risk of cognitive impairment, particularly in the attention/working memory domain. The association of glycaemic control with this domain may indicate cerebrovascular mechanisms.